CYTK (STOCKS)
Cytokinetics Inc.
$66.720000
+1.870000 (+2.88%)
Prev close: $64.850000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Robert I. Blum
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $8,494.87M
- Employees
- 498
- P/E (TTM)
- -10.59
- P/B (TTM)
- -15.65
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
17
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-2.55 | $-1.61 | -0.9385 | -58.24% |
|
Jun 2025 (Q2)
|
$-1.12 | $-1.41 | +0.2850 | +20.28% |
|
Mar 2025 (Q1)
|
$-1.39 | $-1.41 | +0.0192 | +1.36% |
|
Dec 2024 (Q4)
|
$-1.26 | $-1.22 | -0.0433 | -3.56% |
Financial Statements
| Assets | $1.44B |
| Current Assets | $977.35M |
| Cash | $1.30B |
| Noncurrent Assets | $459.21M |
| Fixed Assets | $76.00M |
| Other Non-current Assets | $383.21M |
| Liabilities | $1.96B |
| Current Liabilities | $142.14M |
| Accounts Payable | $22.08M |
| Wages | $33.20M |
| Other Current Liabilities | $86.86M |
| Noncurrent Liabilities | $1.82B |
| Long-term Debt | $1.00B |
| Other Non-current Liabilities | $813.62M |
| Equity | -$521.12M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$521.12M |
| Liabilities And Equity | $1.44B |